Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region

Circulation

Volumn 110, Issue 17, 2004, Pages 2678-2686

  Patel, Anushka ^a,b  

^a Asia Pac Cohort Studs Collab ^*  (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Asia; Cardiovascular diseases; Coronary disease; Stroke; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTICLE; ASIA; AUSTRALIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; STROKE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ASIA; AUSTRALIA; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; RISK FACTORS; TRIGLYCERIDES;

EID: 7544226531     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000145615.33955.83     Document Type: Article

References (46)

1. Assmann G, Schulte H, Funke H, et al. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J. 1998;19(suppl M):M8-M14.
2. Avins AL, Browner WS. Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels: what a difference a decade makes. JAMA. 1998;279:445-449.
3. Bainton D, Miller NE, Bolton CH, et al. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. Br Heart J. 1992;68:60-66.
4. Cambien F, Jacqueson A, Richard JL, et al. Is the level of serum triglyceride a significant predictor of coronary death in " normocholesterolemic" subjects? Am J Epidemiol. 1986;124:624-632.
5. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med. 1993;328:1220-1225.
6. Frost PH, Davis BR, Burlando AJ, et al. Serum lipids and incidence of coronary heart disease: findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation. 1996;94:2381-2388.
7. Gaziano JM, Hennekens CH, O'Donnell CJ, et al. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation. 1997;96:2520-2525.
8. Haim M, Benderly M, Brunner D, et al. Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation. 1999;100:475-482.
9. Iso H, Naito Y, Sato S, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. Am J Epidemiol. 2001; 153:490-499.
10. Jeppesen J, Hein HO, Suadicani P, et al. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation. 1998;97:1029-1036.
11. Stampfer MJ, Krauss RM, Ma J, et al. A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA. 1996;276:882-888.
12. Austin MA, Rodriguez BL, McKnight B, et al. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. Am J Cardiol. 2000;86:412-416.
13. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk. 1996;3:213-219.
14. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
15. Austin MA. Plasma triglyceride and coronary heart disease. Arterioscler Thromb. 1991;11:2-14.
16. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150:341-353.
17. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease, part 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765-774.
18. Jacobs DR Jr, Barrett-Connor E. Retest reliability of plasma cholesterol and triglyceride: the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1982;116:878-885.
19. Egger M, Davey Smith G, Pfluger D, et al. Triglyceride as a risk factor for ischemic heart disease in British men: effect of adjusting for measurement error. Atherosclerosis. 1999;143:275-284.
20. Bhuripanyo K, Tatsanavivat P, Matrakool B, et al. A prevalence survey of lipids abnormalities of rural area in Amphoe Phon, Khon Kaen. J Med Assoc Thai. 1993;76:101-108.
21. Chadha SL, Gopinath N, Shekhawat S. Urban-rural differences in the prevalence of coronary heart disease and its risk factors in Delhi. Bull WHO. 1997;75:31-38.
22. Pan WH, Chiang BN. Plasma lipid profiles and epidemiology of atherosclerotic diseases in Taiwan: a unique experience. Atherosclerosis. 1995; 118:285-295.
23. Park Y, Lee H, Koh CS, et al. Community-based epidemiologic study on atherosclerotic cardiovascular risk factors. Diabetes Res Clin Pract. 1996; 34(suppl):S65-S72.
24. Tao S, Li Y, Xiao Z, et al. Serum lipids and their correlates in Chinese urban and rural populations of Beijing and Guangzhou. Int J Epidemiol. 1992;21:893-903.
25. Chen D, Roman GC, Wu GX, et al. Stroke in China (Sino-MONICA-Beijing study) 1984-1986. Neuroepidemiology. 1992;11:15-23.
26. Khor GL. Cardiovascular epidemiology in the Asia-Pacific region. Asia Pacific J Clin Nutr. 2001;10:76-80.
27. Kimura Y, Takishita S, Muratani H, et al. Demographic study of first-ever stroke and acute myocardial infarction in Okinawa, Japan. Intern Med. 1998;37:736-745.
28. Sekikawa A, Kuller LH, Ueshima H, et al. Coronary heart disease mortality trends in men in the post World War II birth cohorts aged 35-44 in Japan, South Korea and Taiwan compared with the United States. Int J Epidemiol. 1999;28:1044-1049.
29. He Y, Lam TH, Li LS, et al. Triglyceride and coronary heart disease mortality in a 24-year follow-up study in Xi'an, China. Ann Epidemiol. 2004;14:1-7.
30. Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ. 1994;309:11-15.
31. Njolstad I, Arnesen E, Lund-Larsen PG. Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women: a 14-year follow-up of the Finnmark Study. Circulation. 1996;94:2877-2882.
32. Simons LA, McCallum J, Friedlander Y, et al. Risk factors for ischemic stroke: Dubbo Study of the Elderly. Stroke. 1998;29:1341-1346.
33. Tanne D, Koren-Morag N, Graff E, et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation. 2001;104:2892-2897.
34. Wannamethee SG, Shaper AG, Ebrahim S. HDL-cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke. 2000; 31:1882-1888.
35. Asia Pacific Cohort Studies Collaboration. Determinants of cardiovascular disease in the Asia Pacific region: protocol for a collaborative overview of cohort studies. CVD Prevent. 1999;2:281-289.
36. Woodward M. Epidemiology: Study Design and Data Analysis. 2nd ed. Boca Raton, Fla: Chapman and Hall/CRC Press; 2004.
37. Easton DF, Peto J, Babiker AG. Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group. Stats Med. 1991;10:1025-1035.
38. Shafer JL. Analysis of Incomplete Multivariate Data. London, UK: Chapman & Hall; 1997.
39. Barzi F, Woodward M. Imputations of missing values in practice: results from imputations of serum cholesterol in 28 cohort studies. Am J Epidemiol. 2004;160:34-45
40. Rosner B, Spiegelman D, Willet W. Correction of logistic regression relative risk estimates and confidence intervals for measurement error: the case of multiple covariates measured with error. Am J Epidemiol. 1990; 132:734-745.
41. Ebenbichler CF, Kirchmair R, Egger C, et al. Postprandial state and atherosclerosis. Curr Opin Lipidol 1995;6:286-290.
42. Karpe F, Steiner G, Uffelman K, et al. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 1994;106:83-97.
43. Mack WJ, Krauss RM, Hodis HN. Lipoprotein subclasses in the Monitored Atherosclerosis Regression Study (MARS): treatment effects and relation to coronary angiographic progression. Arterioscler Thromb Vasc Biol. 1996;16:697-704.
44. Assmann G, Schulte H, von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol. 1996;77:1179-1184.
45. Thrift AG, Dewey HM, Macdonell RA, et al. Incidence of the major stroke subtypes: initial findings from the North East Melbourne Stroke Incidence Study (NEMESIS). Stroke. 2001;32:1732-1738.
46. Hellerstein MK. Carbohydrate-induced hypertriglyceridemia: modifying factors and implications for cardiovascular risk. Curr Opin Lipidol. 2002; 13:33-40.